Article
Projected 2023 Cost Reduction From Tumor Necrosis Factor α Inhibitor Biosimilars in Dermatology: A National Medicare Analysis
To the Editor:
Although biologics provide major therapeutic benefits for dermatologic conditions, they also come with a substantial cost,...
Article
Concordance Between Dermatologist Self-reported and Industry-Reported Interactions at a National Dermatology Conference
Physician-industry interactions are prevalent. Accurate reporting allows for transparency regarding potential conflicts of interest. This study...